News about "Amneal Pharmaceuticals"

Amneal Launches FDA-Approved Lanreotide Injection in the US

Amneal Pharmaceuticals has launched lanreotide injection in the US following FDA approval, expanding its complex injectable medicines portfolio.

Amneal Pharmaceuticals | 28/09/2026 | By News Bureau

Amneal Completes Kashiv BioSciences Acquisition to Strengthen Biosimilars Business

Amneal has completed its acquisition of Kashiv BioSciences, creating an integrated global biosimilar platform spanning R&D, manufacturing and commercialisation.

Amneal Pharmaceuticals | 11/08/2026 | By News Bureau |  105

Amneal Pharmaceuticals to Acquire Kashiv BioSciences to Create Integrated Global Biosimilar Platform

Amneal Pharmaceuticals to buy Kashiv BioSciences, accelerating biosimilar pipeline and strengthening US market position for affordable medicines.

Amneal Pharmaceuticals | 23/04/2026 | By News Bureau |  189

Amneal Gains US FDA Approval for Prolia and XGEVA Denosumab Biosimilars

The US FDA approvals for Prolia and XGEVA denosumab biosimilars strengthen Amneal’s growing biosimilars portfolio, with the company planning to commercialise six biosimilars across eight presentations by 2027.

Amneal Pharmaceuticals | 23/12/2025 | By News Bureau |  319

Amneal Gets FDA Approval for Epinephrine Vials

The FDA has approved Amneal’s epinephrine injection in both single- and multi-dose vials, strengthening the company’s injectables portfolio with a critical medicine widely used in hospitals for emergency and perioperative care.

Amneal Pharmaceuticals | 10/12/2025 | By Akanki |  208

Amneal Launches BORUZU for Multiple Myeloma and Mantle Cell Lymphoma

BORUZU™ (bortezomib injection), a proteasome inhibitor, is used for the treatment of multiple myeloma and mantle cell lymphoma.

Amneal Pharmaceuticals | 07/04/2025 | By Aishwarya |  390

Amneal Secures FDA Approval for Propofol Injectable Emulsion Single Dose Vials

Propofol is an intravenous drug commonly used in hospitals for the induction and maintenance of anesthesia and sedation.

Amneal Pharmaceuticals | 21/08/2024 | By Aishwarya |  708

Amneal Pharma Gets US FDA Approval for CREXONT Extended-Release Capsules

CREXONT is a novel, oral formulation of carbidopa/levodopa (CD/LD) that combines both immediate-release (IR) granules and extended-release (ER) pellets.

Amneal Pharmaceuticals | 08/08/2024 | By Aishwarya |  1009

Amneal Expands Broad Injectables Portfolio with Addition of Six New Therapies

Amneal Pharmaceuticals has expanded its injectables portfolio with six new injectable product launches during the second quarter of 2024.

Amneal Pharmaceuticals | 11/06/2024 | By Aishwarya |  681

Delegation from HHS and FDA Visit Amneal Manufacturing Site in India

The visit followed the G20 Health Ministers' meeting in Gandhinagar, India, where health ministers from around the world met to discuss global health issues.

Amneal Pharmaceuticals | 01/09/2023 | By Manvi |  1283